Qtern
Qtern is a medicine authorised by Swissmedic under authorisation number 66040. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 June 2017 and the authorisation is valid without a time limit. ATC code A10BD21 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 66040 |
|---|---|
| Name | Qtern |
| Full name | Qtern, Filmtabletten |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BD21 |
| First authorisation | 26 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Qtern, Filmtabletten | B | 26 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | A10BD21 | 07.06.2. | B |
| 2 | 98 | Tablette(n) | A10BD21 | 07.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Qtern authorised in Switzerland?
Yes. Qtern is authorised by Swissmedic under authorisation number 66040, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Qtern have?
Qtern is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Qtern?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.